ValuentumAd

Official PayPal Seal

Valuentum Reports













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Latest Valuentum Commentary

Oct 10, 2014
Transaction Alert: Closing Put Option Contracts
With options, time and volatility can work against you, even if you are directionally right. We’re done playing with ‘fire,’ and we’re taking profits on the put option contracts. We may reinstate the positions at a later date as our cautious outlook remains unchanged.
Oct 1, 2014
October Dividend Growth Newsletter Introduction
Let's get some of our thoughts out there and answer a few questions.
Aug 5, 2014
Big Oil Round Up: Earnings Portal
Let’s put together the calendar second-quarter reports from the oil & gas majors.
Jul 13, 2014
Dividend Increases for the Week Ending July 11
Let's take a look at dividend increases for the week ending July 11.
Jun 22, 2014
Valuentum Economic Castle™ Rating Update
Members should expect the initial Economic Castle™ ratings.
May 6, 2014
Why We’re Keeping Chevron As Our Favorite Dividend Growth Idea in Big Oil
Chevron is our favorite dividend growth idea among the energy majors. Though we don’t necessarily dislike its peers, we think the healthier the balance sheet, the better the dividend expansion through the course of the volatile and unpredictable energy price cycle.
Feb 17, 2014
Deciphering Valuentum’s Dividend Lingo
Let’s examine how some investors are using the framework behind the Valuentum Dividend Cushion, if not the measure itself.
Jan 31, 2014
Chevron’s Balance Sheet Slowly Losing Luster
Our thesis on Chevron is starting to be challenged. We may look at the firm as a source of cash in the Dividend Growth portfolio.
Jan 12, 2014
Chevron Releases Fourth Quarter Update
The oil major’s performance was as expected, and we think the firm is well-positioned for dividend increases.
Jan 3, 2014
Buffett Doubles Down on USG; Teva Expected to Appoint New CEO; Crude by Rail Transportation Comes under Scrutiny
Buffett more than doubles stake in wallboard maker USG, generic pharmaceutical giant Teva rumored to find CEO, while concerns about crude-by-rail heighten.


Latest News and Media

The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.